72 related articles for article (PubMed ID: 9218758)
1. Interleukin-21 (IL-21) synergizes with IL-2 to enhance T-cell receptor-induced human T-cell proliferation and counteracts IL-2/transforming growth factor-β-induced regulatory T-cell development.
Battaglia A; Buzzonetti A; Baranello C; Fanelli M; Fossati M; Catzola V; Scambia G; Fattorossi A
Immunology; 2013 May; 139(1):109-20. PubMed ID: 23278180
[TBL] [Abstract][Full Text] [Related]
2. Distinct regions of the interleukin-7 receptor regulate different Bcl2 family members.
Jiang Q; Li WQ; Hofmeister RR; Young HA; Hodge DR; Keller JR; Khaled AR; Durum SK
Mol Cell Biol; 2004 Jul; 24(14):6501-13. PubMed ID: 15226449
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD137 Ameliorates Acute Type 1 Diabetes by Inducing T Cell Anergy.
Itoh A; Ortiz L; Kachapati K; Wu Y; Adams D; Bednar K; Mukherjee S; Chougnet C; Mittler RS; Chen YG; Dolan L; Ridgway WM
Front Immunol; 2019; 10():2566. PubMed ID: 31787971
[TBL] [Abstract][Full Text] [Related]
4. Excess Salt Intake Activates IL-21-Dominant Autoimmune Diabetogenesis via a Salt-Regulated Ste20-Related Proline/Alanine-Rich Kinase in CD4 T Cells.
Ciou JJ; Chien MW; Hsu CY; Liu YW; Dong JL; Tsai SY; Yang SS; Lin SH; Yen BL; Fu SH; Sytwu HK
Diabetes; 2024 Apr; 73(4):592-603. PubMed ID: 38241027
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Ca2+-independent phospholipase A2β (iPLA2β) ameliorates islet infiltration and incidence of diabetes in NOD mice.
Bone RN; Gai Y; Magrioti V; Kokotou MG; Ali T; Lei X; Tse HM; Kokotos G; Ramanadham S
Diabetes; 2015 Feb; 64(2):541-54. PubMed ID: 25213337
[TBL] [Abstract][Full Text] [Related]
6. Remission of autoimmune diabetes by anti-TCR combination therapies with anti-IL-17A or/and anti-IL-6 in the IDDM rat model of type 1 diabetes.
Jörns A; Ishikawa D; Teraoku H; Yoshimoto T; Wedekind D; Lenzen S
BMC Med; 2020 Feb; 18(1):33. PubMed ID: 32106855
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta, T-cell tolerance and anti-CD3 therapy.
Bommireddy R; Doetschman T
Trends Mol Med; 2004 Jan; 10(1):3-9. PubMed ID: 14720578
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T Cells Conditioned Media Stimulates Migration in HaCaT Keratinocytes: Involvement of Wound Healing.
Kim D; Lo E; Kim D; Kang J
Clin Cosmet Investig Dermatol; 2020; 13():443-453. PubMed ID: 32753927
[TBL] [Abstract][Full Text] [Related]
9. Silver Decorated Mesoporous Carbons for the Treatment of Acute and Chronic Wounds, in a Tissue Regeneration Context.
Torre E; Giasafaki D; Steriotis T; Cassinelli C; Morra M; Fiorilli S; Vitale-Brovarone C; Charalambopoulou G; Iviglia G
Int J Nanomedicine; 2019; 14():10147-10164. PubMed ID: 32021158
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of Glaucoma.
Harrell CR; Fellabaum C; Arsenijevic A; Markovic BS; Djonov V; Volarevic V
Stem Cells Int; 2019; 2019():7869130. PubMed ID: 31949441
[TBL] [Abstract][Full Text] [Related]
11. Manipulating the type 1 vs type 2 balance in type 1 diabetes.
Christen U; von Herrath MG
Immunol Res; 2004; 30(3):309-25. PubMed ID: 15531772
[TBL] [Abstract][Full Text] [Related]
12. Cytokine profile and insulin antibody IgG subclasses in patients with recent onset type 1 diabetes treated with oral insulin.
Monetini L; Cavallo MG; Sarugeri E; Sentinelli F; Stefanini L; Bosi E; Thorpe R; Pozzilli P;
Diabetologia; 2004 Oct; 47(10):1795-802. PubMed ID: 15502927
[TBL] [Abstract][Full Text] [Related]
13. The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases.
Horwitz DA; Gray JD; Zheng SG
Arthritis Res; 2002; 4(4):241-6. PubMed ID: 12106494
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-10-secreting Peyer's patch cells are responsible for active suppression in low-dose oral tolerance.
Tsuji NM; Mizumachi K; Kurisaki J
Immunology; 2001 Aug; 103(4):458-64. PubMed ID: 11529936
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 2 receptor signaling regulates the perforin gene through signal transducer and activator of transcription (Stat)5 activation of two enhancers.
Zhang J; Scordi I; Smyth MJ; Lichtenheld MG
J Exp Med; 1999 Nov; 190(9):1297-308. PubMed ID: 10544201
[TBL] [Abstract][Full Text] [Related]
16. DNA immunization to prevent autoimmune diabetes.
Coon B; An LL; Whitton JL; von Herrath MG
J Clin Invest; 1999 Jul; 104(2):189-94. PubMed ID: 10411548
[TBL] [Abstract][Full Text] [Related]
17. Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice.
Yasuda H; Nagata M; Arisawa K; Yoshida R; Fujihira K; Okamoto N; Moriyama H; Miki M; Saito I; Hamada H; Yokono K; Kasuga M
J Clin Invest; 1998 Nov; 102(10):1807-14. PubMed ID: 9819366
[TBL] [Abstract][Full Text] [Related]
18. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.
Thornton AM; Shevach EM
J Exp Med; 1998 Jul; 188(2):287-96. PubMed ID: 9670041
[TBL] [Abstract][Full Text] [Related]
19. Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice.
Han HS; Jun HS; Utsugi T; Yoon JW
J Autoimmun; 1997 Jun; 10(3):299-307. PubMed ID: 9218758
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
